Clinical Trial

Effects of a Isokinetic Exercise in Women With Fibromyalgia

Study acronym: FibrodEx
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 16, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Fibromyalgia is a chronic syndrome characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and functional impairment, which significantly affects quality of life. Physical exercise is considered one of the most effective non-pharmacological interventions for the management of this condition; however, uncertainty remains regarding the most appropriate type, intensity, and frequency of exercise for different patient profiles. The aim of this study is to analyze the effects of a microdoses isokinetic exercise program on physical condition, perceived pain, inflammatory profile and quality of life in women diagnosed with fibromyalgia.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-04-17
notable Primary completion pushed: 2026-06 -> 2026-07 2026-04-17
minor Completion pushed: 2026-06 -> 2026-07 2026-04-17
Trial Details
NCT Number NCT07483216
Lead Sponsor European University Miguel de Cervantes
Conditions Fibromyalgia (FM)
Enrollment 36 participants
Start Date 2026-04
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-04-16